How We’re Improving the Supply Chain of Pharmaceutical Products

Our Auditing Program and Licensed Audit Reports

Members have access to Rx-360’s Joint Audit Program, which minimizes on-site audits for suppliers, streamlines audit function efficiency, and improves audit quality and thoroughness using industry resources. All ongoing audits are viewable in real-time and all audit reports generated through the Rx-360 Audit Program can be utilized by licensees.

How We Identify Supply Chain Issues in the Pharmaceutical Industry

Supply chains have become more global, complex and increasingly vulnerable to adulteration and counterfeiting. To combat this, Rx-360 has increased its focus on strong partnerships between pharmaceutical manufacturers and suppliers to ensure the integrity of supply chains through on-site auditing. The audit process is completely transparent to members, showcasing supplier and sponsor review and critical audit findings to flag any potential issues.

Since Our inception, we’ve worked across the globe

 

How We Deliver Greater Pharma Patient Safety

Rx-360 prioritizes patient safety by gathering industry peers to share ideas in a confidential environment, improve knowledge base and preparation within the industry, drive industry-wise standards and guidelines, identify and mitigate global supply chain risks, and improve audit quality and thoroughness. Join the movement today.

BECOME A MEMBER

CONNECT AND COLLABORATE
WITH THE BEST PHARMACEUTICAL
THOUGHT LEADERS ON EARTH

  • Ensure there are no bad actors in your supply chain.
  • Gain best practices from top pharmaceutical companies.
  • Band together to protect patient safety.

JOIN THE CONSORTIUM

Member Organizations

One consortium dedicated to
ensuring supply chain integrity
and protecting patient safety

JOIN THE CONSORTIUM

Case Studies

Rx-360 Helps GSK Reduce Audit Costs and Improve Efficiencies

Gary Armstrong, GSK

DOWNLOAD

 

 

Rx-360 Helps NewAge Industries Reduce Audit Costs & Save Time

NewAge Industries

DOWNLOAD

Underlying Benefits of Working Groups

Daniel Ewald, Boehringer Ingelheim

Expansion of DI knowledge

DOWNLOAD

AOG-Remote Audits

Imelda Meyer-Wilmes, MilliporeSigma

Remote Audits instead of on-site audit due to COVID-19 Travel Restrictions

DOWNLOAD

BECOME A KEY PLAYER IN PROTECTING PATIENT SAFETY

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.